Legacy Capital Group California Inc. Purchases 39 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Legacy Capital Group California Inc. increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.7% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 724 shares of the biotechnology company’s stock after acquiring an additional 39 shares during the period. Legacy Capital Group California Inc.’s holdings in Axon Enterprise were worth $289,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in AXON. Quent Capital LLC grew its stake in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares during the period. Blue Trust Inc. raised its stake in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares during the last quarter. Friedenthal Financial bought a new position in shares of Axon Enterprise during the 3rd quarter valued at $51,000. Asset Dedication LLC bought a new position in shares of Axon Enterprise during the 2nd quarter valued at $47,000. Finally, Cullen Frost Bankers Inc. purchased a new position in shares of Axon Enterprise in the 2nd quarter worth $59,000. 79.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of recent research reports. JMP Securities increased their target price on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Bank of America assumed coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $380.00 target price for the company. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $400.00 to $525.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Craig Hallum upped their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $382.85.

Insider Transactions at Axon Enterprise

In related news, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares in the company, valued at $37,449,733.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the completion of the transaction, the director now directly owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 371,172 shares of company stock valued at $137,000,162. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Trading Up 0.3 %

AXON stock opened at $444.52 on Friday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52. Axon Enterprise, Inc. has a 1-year low of $199.29 and a 1-year high of $455.17. The business has a 50 day simple moving average of $396.09 and a two-hundred day simple moving average of $336.34. The company has a market capitalization of $33.55 billion, a price-to-earnings ratio of 129.98, a PEG ratio of 12.05 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. Axon Enterprise’s quarterly revenue was up 34.5% on a year-over-year basis. During the same period last year, the company posted $0.80 earnings per share. Research analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.